Primary hepatocellular carcinoma and metabolic syndrome: An update

doi:10.4251/wjgo.v5.i9.186

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 5, Issue 9

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (9131)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-1) series, Tables (1-4) series.

Item

Count

PDF

551

HTML

6912

Figures (1-1)

293

Tables (1-4)

210

Sum=7966

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

616

Download

549

Sum=1165

Sep 15, 2013 (publication date) through Nov 5, 2024

Times Cited of This Article

Times Cited (57)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Gastrointest Oncol. Sep 15, 2013; 5(9): 186-194
Published online Sep 15, 2013. doi: 10.4251/wjgo.v5.i9.186

Open in New Tab Full Size Figure Download Figure

Figure 1 Pathogenesis of hepatocellular carcinoma in the background of metabolic syndrome. PPAR: Peroxisome proliferator-activated receptors; NASH: Nonalcoholic steatohepatitis; FFA: Free fatty acid; IRS-1: Insulin receptor substrate 1; TNF-α: Tumor necrosis factor α.

Citation: Rahman R, Hammoud GM, Almashhrawi AA, Ahmed KT, Ibdah JA. Primary hepatocellular carcinoma and metabolic syndrome: An update. World J Gastrointest Oncol 2013; 5(9): 186-194
URL: https://www.wjgnet.com/1948-5204/full/v5/i9/186.htm
DOI: https://dx.doi.org/10.4251/wjgo.v5.i9.186